The growing crisis of drugs in prisons is creating severe challenges across UK correctional facilities, as outlined in a recent Justice Select Committee inquiry. Natalie McKee, Governor of HMP Hindley, shared alarming insights, revealing how weekly drone sightings, soaring prisoner debts, and high drug test failure rates are disrupting safety and rehabilitation.

Drugs in Prisons Linked to Violence and Debt

HMP Hindley, which accommodates 600 inmates, is battling one of the country’s gravest drug issues. Up to 150 drone deliveries of illicit substances were recorded in a single year, with packages being dropped directly to prisoners’ cells. This has contributed to a staggering failure rate of nearly 50 per cent in random drug tests, climbing higher than 70 per cent at its worst. Increased ketamine use, alongside cannabis and psychoactive substances, has worsened conditions, compounded by understaffed educational and occupational programmes.

The prison drug crisis extends beyond prison walls, affecting families and communities. Violent incidents are increasingly linked to drug-related debts, with some families footing bills of up to £10,000 for their loved ones. Staff also endure harrowing challenges, often witnessing inmates suffering severe effects from substance misuse, which compromises overall safety.

Combating the Prison Drug Crisis with Strategic Solutions

Governors across the UK are spearheading initiatives to mitigate the supply and impact of drugs in prisons. Babafemi Dada, Governor of HMP Long Lartin, has expanded drug rehabilitation spaces, while Rob Luxford of HMP Liverpool advocated for a health-based strategy to address addiction. Both stressed that community drug problems fuel the high rates of substance misuse seen among inmates.

While drones remain the most prevalent smuggling method, staff corruption also contributes. Enhanced gate security, like measures introduced by Dada at HMP Gartree, has helped curb insider smuggling. Other strategies, including drug-free wings and treatment options such as Buvidal for opioid dependence, show promise. However, consistent implementation and robust post-release support are essential for long-term success.

These efforts underline the critical need to eliminate illicit substances from prisons, fostering safer environments and promoting effective rehabilitation.

Source: InsideTime